Search Within

Margaret Kathleen Callahan

Formats
  1. Journal Article (104)
  2. Meeting Abstract (83)
  3. Editorial (4)
  4. Book Section (2)
  5. Research Letter (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Department of Medicine (197)
  2. Melanoma and Immunotherapeutics Service (197)
  3. Solid Tumor Oncology Division (197)
  4. GSK Faculty (123)
  5. Melanoma Disease Management Team (107)
  6. Hematologic Malignancies, Division of (76)

More Groups

People
  1. Jedd Wolchok (113)
  2. Michael Postow (95)
  3. Paul Chapman (49)
  4. Alexander Shoushtari (45)
  5. Katherine Panageas (38)
  6. Parisa Momtaz (29)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (11)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (60)
  2. Journal for ImmunoTherapy of Cancer (17)
  3. Science Translational Medicine (10)
  4. Annals of Oncology (7)
  5. Clinical Cancer Research (7)
  6. New England Journal of Medicine (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (64)
  2. Biomed Central Ltd (17)
  3. Elsevier Inc. (17)
  4. American Association for Cancer Research (15)
  5. Oxford University Press (15)
  6. Nature Publishing Group (11)

More Publishers

Results (197)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer
    Meeting Abstract

    Naing, A.; Callahan, M.; Costello, B.; Curti, B.; Hall, E.; Hansen, A.; Long, G.; Joshua, A.; Shankles, B.; Ulge, U.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors
    Meeting Abstract

    Sarfaty, M.; Desjardins, C. A.; Giardina, P.; Bardhan, K.; Pandian, S.; Halley, K.; Halvorsen, E. M.; Callahan, M. K.; Postow, M. A.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
    Journal Article

    Ogishi, M.; Yang, R.; Aytekin, C.; Langlais, D.; Bourgey, M.; Khan, T.; Al Ali, F.; Rahman, M.; Delmonte, O. M.; Chrabieh, M.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
    Journal Article

    Shen, R.; Postow, M. A.; Adamow, M.; Arora, A.; Hannum, M.; Maher, C.; Wong, P.; Curran, M. A.; Hollmann, T. J.; Jia, L.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
    Journal Article

    Andrews, M. C.; Duong, C. P. M.; Gopalakrishnan, V.; Iebba, V.; Chen, W. S.; Derosa, L.; Khan, M. A. W.; Cogdill, A. P.; White, M. G.; Wong, M. C.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
    Journal Article

    Beattie, J.; Rizvi, H.; Fuentes, P.; Luo, J.; Schoenfeld, A.; Lin, I. H.; Postow, M.; Callahan, M.; Voss, M. H.; Shah, N. J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save